(Sharecast News) - London stock markets closed in the red on Friday as sharp declines in airline, mining, and housebuilding stocks weighed on indices, with a lack of significant news and profit-taking ...
In contrast to the gloomy mood in Europe, US markets pushed higher. At the time of the London close, the Dow Jones Industrial Average was up 0.6%, the S&P 500 was 1.0% higher and the Nasdaq Composite ...
Volex said the acquisition has exceeded earnings before interest, tax, depreciation and amortisation targets set in the acquisition agreement during the first 12 months. Therefore, the company will ...
(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.
The FTSE 100 index opened down 5.86 points, 0.1%, at 8,254.23. The FTSE 250 was down 51.56 points, 0.3%, at 20,588.67, and the AIM All-Share was down just 0.01 of a point at 723.69.
(Alliance News) - The UK manufacturing sector downturn deepened more sharply than expected last month, a survey on Thursday showed, with the fastest rate of decline since last January.
(Alliance News) - Emmerson PLC on Thursday said it has signed a deal with a specialist litigation funding firm to secure USD11.0 million in financing. The funding will go towards a dispute with the ...
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.
Chair Eric Sanderson said the sale of EMIC-1 is a "key milestone for progressing the wind-down of the company". The deal can allow the firm to "further deleverage its balance sheet" by trimming the ...
The FTSE 100 index ended up 52.01 points, 0.6%, at 8,173.02. It is up 5.7% for the year. It is the best year for the blue-chip index since 2021, when it jumped 14% on a post-Covid recovery. In 2022, ...
(Sharecast News) - UK stocks opened flat on Tuesday morning ahead of an early finish in London, with investors adopting a cautious approach on the final trading day of the year.
(Alliance News) - Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation licence for Sareum's SRA737 clinical-stage cancer ...